Skip to content
Home / Companies / SVRA SVR
Savara Inc (SVRA) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest SVRA Insider Trades Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Headquarters AUSTIN, TX
Employees 70
Listed 1996
Exchange XNAS https://www.savarapharma.com SEC filings for SVRA on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 1 394,528 $2.24M Grant or award 2 105,000 Option exercise 12 1,160,374
SVRA Insider Transactions (Form 4) 81 38 Form 4 filings on record, the earliest from Oct 22, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Jul 15, 2026 RL Robert Matthew Lutz - Officer Grant or award Common Stock 35,000
Recent SVRA Form 8-K Filings 2
Recent SVRA Form 144 Notices of Proposed Sale 1 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jun 22, 2026 - - - - View on EDGAR
SVRA Insider Trading - FAQ
What is the latest insider trade for SVRA? Savara Inc (SVRA) had 2 insider filings in the last 90 days, with the most recent on 2026-07-24. The full record for SVRA runs to 38 Form 4 filings, the earliest from 2024-10-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying SVRA stock? No insider purchases of SVRA were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling SVRA stock? 1 insider sale of SVRA was filed in the last 90 days, totaling $2.24M.
Where can I see SVRA SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks SVRA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow SVRA insider buys? Create a free InsiderAlpha account and press Watch on this page to add SVRA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Jul 24, 2026 - Robert Matthew Lutz view on EDGAR Jun 23, 2026 - David L. Lowrance view on EDGAR Mar 20, 2026 - David L. Lowrance view on EDGAR Feb 17, 2026 - Joseph S. McCracken view on EDGAR Dec 19, 2025 - David A. Ramsay view on EDGAR Dec 16, 2025 - David L. Lowrance view on EDGAR Dec 16, 2025 - Matthew Pauls view on EDGAR Dec 16, 2025 - Robert Matthew Lutz view on EDGAR Dec 16, 2025 - Kathleen R. McCabe view on EDGAR Dec 16, 2025 - Anne Erickson
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track SVRA insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $1.08B
P/E ratio -
Dividend yield -
Average volume 1.83M
52 week high $7.01
52 week low $3.19
Today's high $5.51
Today's low $5.25
Open $5.48
Volume 1.34M
Previous close $5.49
Shares outstanding 205.46M Market cap
$1.08B
70 employees
SVRA Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 1 sale totaling $2.24M.
Most-Active SVRA Insiders - Last 90 Days 10 Tax withholding / forfeiture 6 185,659
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jul 15, 2026 RL Robert Matthew Lutz - Officer Grant or award Stock Option (Right to Buy) 70,000 $0.00 -
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 56,937 $0.00 -
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 218,750 $0.00 -
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 12,500 $0.00 -
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 87,650 $0.00 -
Jun 22, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 21,682 $5.50 $119K
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Common Stock 129,350 $1.23 $159K
Jun 22, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 28,928 $5.50 $159K
Jun 22, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 11,491 $5.50 $63K
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Common Stock 218,750 $1.51 $330K
Jun 22, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 60,057 $5.50 $330K
Jun 22, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 10,114 $5.50 $56K
Jun 22, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 53,387 $5.50 $294K
Jun 22, 2026 DL David L. Lowrance - Officer Open-market sale Common Stock 394,528 $5.68 $2.24M
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 75,000 $0.00 -
Jun 22, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 129,350 $0.00 -
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Common Stock 130,650 $1.23 $161K
Mar 18, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 24,174 $5.04 $122K
Mar 18, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 23,661 $5.04 $119K
Mar 18, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 31,885 $5.04 $161K
Mar 18, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 9,485 $5.04 $48K
Mar 18, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 11,037 $5.04 $56K
Mar 18, 2026 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 16,518 $5.04 $83K
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 80,684 $0.00 -
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 75,000 $0.00 -
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 130,650 $0.00 -
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 43,063 $0.00 -
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 12,500 $0.00 -
Mar 18, 2026 DL David L. Lowrance - Officer Option exercise Stock Option (Right to Buy) 24,850 $0.00 -
Dec 14, 2025 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 62,960 $6.92 $436K
Dec 14, 2025 MP Matthew Pauls - Officer Tax withholding / forfeiture Common Stock 195,705 $6.92 $1.35M
Dec 16, 2025 MP Matthew Pauls - Officer Gift Common Stock 128,995 $0.00 -
Dec 14, 2025 RL Robert Matthew Lutz - Officer Tax withholding / forfeiture Common Stock 67,760 $6.92 $469K
Dec 14, 2025 KM Kathleen R. McCabe - Officer Tax withholding / forfeiture Common Stock 39,350 $6.92 $272K
Dec 14, 2025 AE Anne Erickson - Officer Tax withholding / forfeiture Common Stock 62,960 $6.92 $436K
Dec 10, 2025 MP Matthew Pauls - Officer Gift Common Stock 23,629 $0.00 -
Dec 4, 2025 YW Yasmine Wasfi - Officer Tax withholding / forfeiture Common Stock 21,992 $6.37 $140K
Dec 2, 2025 NE Nevan C. Elam Option exercise Common Stock 5,860 $1.46 $9K
Dec 2, 2025 NE Nevan C. Elam Tax withholding / forfeiture Common Stock 1,473 $5.81 $9K
Dec 2, 2025 NE Nevan C. Elam Option exercise Stock Option (Right to Buy) 5,860 $0.00 -
Oct 20, 2025 YW Yasmine Wasfi - Officer Grant or award Common Stock 35,000 $0.00 -
Oct 20, 2025 YW Yasmine Wasfi - Officer Grant or award Stock Option (Right to Buy) 70,000 $0.00 -
Mar 31, 2025 DR David A. Ramsay Open-market purchase Common Stock 150,000 $2.78 $416K
Dec 12, 2024 AE Anne Erickson - Officer Grant or award Common Stock 100,000 $0.00 -
Dec 13, 2024 AE Anne Erickson - Officer Tax withholding / forfeiture Common Stock 18,263 $3.21 $59K
Dec 12, 2024 AE Anne Erickson - Officer Grant or award Stock Option (Right to Buy) 300,000 $0.00 -
Dec 12, 2024 NE Nevan C. Elam Grant or award Common Stock 40,000 $0.00 -
Dec 13, 2024 DL David L. Lowrance - Officer Tax withholding / forfeiture Common Stock 24,350 $3.21 $78K
Dec 12, 2024 DL David L. Lowrance - Officer Grant or award Stock Option (Right to Buy) 300,000 $0.00 -
$CORT
CORCEPT THERAPEUTICS INC
